The International Journal of Biochemistry & Cell Biology
ReviewTranscriptional regulators in mammary gland development and cancer
Introduction
A central question in developmental biology is the nature of the transcriptional circuitry that controls cell-fate determination and differentiation in a given organ or tissue. Transcription factors have been shown to have critical roles in numerous cellular systems, using targeted gene deletion together with gain-of-function studies. For example, MyoD, SCL, NeuroD, and Nkx2.5 have essential roles in muscle, hemopoietic, neuronal and heart development, respectively (Biben, Palmer, Elliott, & Harvey, 1997; Massari & Murre, 2000; Weintraub et al., 1991). Although some transcriptional regulators are restricted to specific lineages, most are expressed in multiple lineages and in several different organs. Within breast tissue, few cell-restricted transcription factors have been identified. While the estrogen and progesterone steroid hormone receptors display restricted expression profiles, the majority of regulators are also found in several tissues outside of this organ. It therefore appears likely that these transcription factors serve more than one function through their combinatorial association with distinct proteins in different cell types (Table 1).
Over the past few years, significant new insights have been made in our understanding of transcription factors and cofactors that guide development in the mammary gland. This review will highlight key nuclear regulatory proteins, many of which have been established to have critical roles in the mammary gland through their targeted deletion. Some of these transcription factors, upon deregulation, have been implicated in breast oncogenesis. We will discuss potential targets and mechanisms by which these factors may perturb normal breast epithelial cell development.
Section snippets
Development of the mammary gland
Development of the mammary gland occurs in distinct stages, initiating in the embryo but occurring primarily in the peripubertal animal. Both systemic hormones and the mammary stroma are critical for mammopoiesis. The rudimentary mammary gland first emerges in the embryo around day 10, evident as five pairs of placodes. By day 15, these have formed epithelial buds surrounded by mesenchymal cell layers (termed the primary mammary mesenchyme). Further development of the buds into ductal
LEF1 and epithelial–mesenchymal signaling in the embryo
LEF1 (lymphocyte enhancer factor 1) and the homeobox genes Msx1 and Msx2 (see below), play important roles in the development of the mammary gland primordia within the embryo. Abundant LEF1 RNA is visible in the mammary bud at E11.0 (van Genderen et al., 1994). Expression subsequently switches to the surrounding mammary mesenchymal cells. Within the adult mammary gland, LEF1 expression is very low. Targeted deletion of LEF1 in mice leads to an arrest in mammary organogenesis at a very early
Homeobox genes in mammary gland development and neoplasia
Over the past two decades homeobox genes have emerged as key regulators of developmental decisions. They play a direct role in cell-fate specification and maintenance of cell identity. Given their essential roles in the formation of several organs, including the CNS and skeleton, it seemed likely that they would participate in controlling one or more aspects of mammary gland development. The hallmark of this family is a helix-turn-helix DNA-binding domain, which mediates binding to a TAAT
Steroid hormone receptors and adult mammary gland development
Mammary gland development in the pubertal and reproductive phases is dependent on systemic hormones. Both estrogen and progesterone are required for ductal epithelial outgrowth and secretory function in the mammary gland (Imagawa et al., 1994). The regression of ducts and alveolar structures that occurs following removal of the ovaries can be rescued by exogenous estrogen or progesterone. Specific roles for the estrogen and progesterone receptors (ER and PR) and their coactivators have been
Stat3 and Stat5 in mammopoiesis
Prolactin is essential for expansion and differentiation of the mammary lobuloalveolar epithelium (Topper & Freeman, 1980). Targeted disruption of the prolactin receptor (PRLR), Janus-2 kinase (Jak2) and the transcription factor Stat5 has highlighted the importance of the prolactin pathway for mammopoiesis in vivo. Binding of prolactin to its cognate receptor triggers dimerisation and results in the recruitment and activation of Jak2. Activated Jak2 then phosphorylates the receptor and signal
Helix-loop-helix (HLH) genes in mammary development
The HLH class of transcription factors play critical roles in cell-fate determination and differentiation in numerous developmental systems. Id proteins act as dominant negative regulators of these DNA-binding transcription factors (Benezra, Davis, Lockshon, Turner, & Weintraub, 1990). The Id family comprises three members, each of which harbors an HLH motif that mediates dimerisation, but lacks the adjacent DNA-binding motif. Both Id1 and Id2 have roles within the mammary gland. Constitutive
c-myc
The proto-oncogene c-myc encodes a transcription factor that has a central role in regulating cell proliferation, and under stress conditions, triggering apoptosis (reviewed in Cole & McMahon, 1999; Dang, 1999). The c-myc protein contains a basic-helix-loop-helix/leucine zipper domain that mediates dimerisation with its partner Max, and has the ability to drive cells through G1/S transition. myc-max heterodimers apparently regulate gene activity through chromatin remodeling. The c-myc promoter
Conclusion
Transcription factors play an essential role in mammary gland development. The vast majority of these factors are also widely expressed in tissues outside of the mammary gland. The specific function of these regulatory proteins in mammary gland morphogenesis is likely to reflect the presence of cell-restricted cofactors and combinatorial action with other proteins. Recent work has revealed that many of these transcription factors are important for programming lobuloalveolar expansion and
Acknowledgements
Owing to space constraints, it has not been possible to cite all relevant publications. We thank Peter Maltezos for preparation of the figures, and Drs. S. Gerondakis and E. Thompson for helpful comments on the manuscript. The authors are supported by the Victorian Breast Cancer Research Consortium Inc. (Australia) and the Bone Marrow Research Laboratories, Royal Melbourne Hospital.
References (106)
- et al.
Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium
American Journal of Pathology
(1999) - et al.
The protein Id: a negative regulator of helix-loop-helix DNA binding proteins
Cell
(1990) - et al.
Stat3 as an oncogene
Cell
(1999) - et al.
TCF/LEF factor earn their wings
Trends Genetics
(1997) The function and evolution of Msx genes: pointers and paradoxes
Trends Genetics
(1995)- et al.
Differential modulation of transcriptional activity of estrogen receptors by direct protein–protein interactions with the T cell factor family of transcription factors
Journal Biological Chemistry
(2001) - et al.
Regulated expression of homeobox genes Msx-1 and Msx-2 in mouse mammary gland development suggests a role in hormone action and epithelial–stromal interactions
Development Biology
(1996) - et al.
Oncogenic Neu/ErbB-2 increases Ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting Ets activation blocks Neu-mediated cellular transformation
Journal Biological Chemistry
(1996) - et al.
HMG domain proteins: architectural elements in the assembly of nucleoprotein structures
Trends Genetics
(1994) - et al.
The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and downregulators
Lancet Oncology
(2002)